EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access

Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Nushrat Sultana iD, Francis J Ha, Anthony White, Adam J Brown, Nitesh Nerlekar

International Journal of Angiology · 01.12.2025 · 34 (04) · 360-369

DOI: 10.1055/a-2652-1902 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Angiology, erschienen am 01.12.2025. Verfasst von Nushrat Sultana und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Victorian Heart Hospital, Monash Health, Melbourne, Australia. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The optimal management strategy for stable coronary artery disease (CAD) remains contentious. While revascularization benefits acute coronary syndromes, its role in stable CAD compared with medical therapy (MT) is less clear. This systematic review and meta-analysis evaluated the safety and efficacy of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) versus MT in patients with stable CAD. A systematic search identified randomized trials comparing revascularization with optimal MT in stable CAD. Trials included documented CAD via angiography and excluded acute coronary syndromes. The primary safety endpoint was all-cause mortality, non-fatal myocardial infarction (MI), and stroke. The primary efficacy endpoint also included unplanned revascularization, cardiac hospitalization, and major bleeding. The secondary endpoint included the percentage free from angina. Relative risk (RR) was calculated using random-effects models. Ten trials with 14,171 participants were included. There was no difference in the primary safety endpoint (RR 0.96 [0.90–1.03], p = 0.23). The primary efficacy endpoint favored revascularization (RR 0.81 [0.69–0.96], p = 0.01), primarily driven by unplanned revascularization (RR 0.5 [0.29–0.85], p = 0.01), though with increased procedural MI risk (RR 2.21 [1.44–3.39], p < 0.001). More patients had freedom from angina with revascularization compared with MT (71.8% vs. 62.9%, p < 0.001). In stable CAD, initial revascularization did not improve outcomes for the primary safety endpoint; however, it did reduce unplanned revascularization compared with MT. More patients had freedom from angina in the revascularization arm, at the cost of increased procedural MI. Decision regarding optimal management strategy for stable CAD remains a patient-centered discussion, recognizing the largely symptomatic rather than prognostic benefit that patients derive from early revascularization.

Schlagwörter

Stichwörter der Autor:innen

coronary artery bypass graftingcoronary artery diseasemedical therapymeta-analysispercutaneous coronary interventionrandomized controlled trials

Autor:innen und Institutionen

  • Department of Cardiology, Victorian Heart Hospital, Monash Health, Melbourne, Australia.
  • Department of Cardiology, Victorian Heart Institute, Monash University, Melbourne, Australia.
  • Department of Imaging Research, Baker Heart and Diabetes Institute, Melbourne, Australia.

ORCID-Profile: Nushrat Sultana

Zitieren

APA

Sultana, N., Ha, F. J., White, A., Brown, A. J., & Nerlekar, N. (2025). Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. International Journal of Angiology, 34(04), 360-369. https://doi.org/10.1055/a-2652-1902

Vancouver

Sultana N, Ha FJ, White A, Brown AJ, Nerlekar N. Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. International Journal of Angiology. 2025;34(04):360-369. doi:10.1055/a-2652-1902

BibTeX
@article{Sultana2025,
  author = {Sultana, Nushrat and Ha, Francis J and White, Anthony and Brown, Adam J and Nerlekar, Nitesh},
  title = {Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials},
  journal = {International Journal of Angiology},
  year = {2025},
  volume = {34},
  number = {04},
  pages = {360--369},
  doi = {10.1055/a-2652-1902}
}
Kostenlos starten →